US COVID-19 Vaccine Program Expanding Again


Dr. Anthony Fauci believes the Johnson & Johnson vaccine pause will soon end.

This article was originally published in ContagionLive.

As of April 19, every state in the US expanded its COVID-19 vaccine eligibility to include all adults over the age of 16 to meet the standard President Joe Biden put forth in early April.

The country is now administering 3.2 million doses a day on average, and half of adults have now received at least 1 dose. Additionally, 84.3 million people have now been fully vaccinated against the disease.

On Sunday, the nation’s top infectious disease expert Anthony S. Fauci, MD, said that he believed the pause on the Johnson & Johnson COVID-19 vaccine will likely be lifted on Friday.

During interviews on talk shows, Fauci stated that he expected federal health officials to decide on the vaccine’s future by the end of the week and that he did not anticipate the vaccine being permanently banned.

In a statement on Monday, Pfizer and BioNTech announced that they will supply an additional 100 million dose to the European Union, bringing the total number of vaccines the 2 companies have supplied to 600 million doses.

The Union hopes that the additional doses will help to accelerate the inoculation program.

United States

209.41 million

62.61 per 100


192.13 million

13.35 per 100


123.85 million

8.97 per 100

United Kingdom

42.78 million

63.02 per 100


32.81 million

15.44 per 100


21.95 million

26.19 per 100


19.97 million

23.68 per 100


17.01 million

24.97 per 100


16.69 million

6.1 per 100


16.17 million

11.08 per 100

Data Table per Our World in Data (April 18, 2021, 12 AM EST)

In the US, Dr. Anthony Fauci also added to his remarks that he believes all children will most likely be eligible to receive a vaccination by the first quarter of 2022. He said he thinks all children of basically any age should be able to receive a shot against COVID-19, and expects high school kids to be eligible by the fall.



66.03 per 100



57.03 per 100

New York


69.55 per 100



62.37 per 100



66.53 per 100



64.63 per 100



62.79 per 100

New Jersey


70.58 per 100

North Carolina


59.53 per 100



61.66 per 100

Data Table per CDC COVID-19 Tracker (April 18, 2021, 6 AM EST)

For more information on COVID-19 vaccination research, distribution, and assessment, check out some of these recent Contagion stories:

COVID-19 Thrombotic Risk: Vaccines, The Virus, and Its Patients

Pathogenesis of Clots Following COVID-19 Vaccine Suggests Choice of Treatments

BNT162b2: The First COVID-19 Vaccine

Related Videos
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Mikkael Sekeres, MD:
© 2024 MJH Life Sciences

All rights reserved.